norepinephrine, 16 mg, added to dextrose 5% 250 mL, IV Bag, CONCENTRATION 64 mcg/mL, Rx Only, Cen...

FDA Recall #D-0988-2023 — Class II — July 14, 2023

Recall #D-0988-2023 Date: July 14, 2023 Classification: Class II Status: Terminated

Product Description

norepinephrine, 16 mg, added to dextrose 5% 250 mL, IV Bag, CONCENTRATION 64 mcg/mL, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC 72196-8095-1

Reason for Recall

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Recalling Firm

Central Admixture Pharmacy Services, Inc. — Phoenix, AZ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

80 bags

Distribution

Nationwide in the USA

Code Information

Lot: 36-257069, Exp. 9/14/2023.

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated